If you are already infected with HPV the risk of getting precancerous lesions/cancer may increase between 30% and 44.6% after HPV vaccination according to Merck’s own briefing document submitted to the FDA in 2006 [click here to read]. The Merck sponsored clinical study 13 exposed 156 people to Gardasil and 137 to a placebo who tested positive for one of the strains of HPV contained in the vaccine. The results showed 31 of the 156 people exposed to Gardasil developed cervical cancer as opposed to only 19 in the placebo group. Since study 13 there have been at least 278 reports of cervical cancer post-vaccination.
Read more ...Tuesday, 27 July 2010 20:54
No Comments
Monday, 26 July 2010 23:43
No Comments
The second trial over the drug Fosamax resulted in a verdict of $8 million dollars for Shirely Boles. Mrs. Boles, 71, sued Merck for jaw damage (dead jaw) resulting from her use of the osteoporosis drug Fosamax for 9 years.
Merck’s Fosamax (drug: Alendronate) is used to treat two bone disorders, osteoporosis in postmenopausal women and Paget’s disease. Osteoporosis causes a decrease in bone mass volume and reduction in bone strength leading to fracture of spine, wrist and hip. In Paget’s disease, healthy bone is deteriorated to poor quality bone resulting in many bone disorders. Fosamax was the first of a class of drugs called bisphosphonates which gave women an alternative to traditional treatments for osteoporosis (estrogen (female sex hormone) and calcitonin).
Read more ...
Monday, 26 July 2010 22:17
No Comments
Our Gardasil injury lawyers are investigating serious side effects linked to Gardasil, including blood clots, neurological disorders and even death. Gardasil was approved by the FDA in June 2006. As of June 30, 2008, there have been 9,749 VAERS reports of adverse events following vaccination with Merck’s Gardasil HPV vaccine. Of these, 94% were classified as reports of non-serious adverse reactions events, and 6% as serious adverse reactions.
Read more ...
